Derek Finnegan I have a running note on my phone—the kind that gets longer whenever I’m in the back of a black cab or hovering near a crowded café. It’s titled: “Things people assume are illegal but are not.” For a long time, the top of that list was “medical cannabis.” Even six years after the law changed in the UK, the hushed tones remain. Pretty simple.. People still look at you sideways if you mention that, yes, since November 2018, specialist doctors have been able to prescribe cannabis-based products for medicinal use (CBPMs) for specific conditions where other treatments haven’t worked.
But here is where the conversation often goes off the rails. It either devolves into “wellness” influencers claiming it is a panacea for everything from mild stress to existential dread, or it gets dangerously conflated with recreational cannabis use. Both are unhelpful. Both are intellectually lazy. And both ignore the reason I spent nine years covering digital health: the patient’s clinical safety.
When we talk about medical cannabis in the UK, we aren’t talking about the “wellness” trend of the week. We are talking about clinical oversight, evidence-based titration, and the shift from “trying everything under the sun” to measurable, daily functioning.
The 2018 Reality Check: Not a Wild West
The most important thing to understand is that the legal framework for medical cannabis in the UK is remarkably stringent. It is not an over-the-counter remedy. It is not something you buy in a health food shop to “boost your glow.” If you are buying it in a shop on the high street that doesn’t ask for a prescription, you are likely buying high-street CBD, which is a nutritional supplement, not a medical-grade treatment.
In the medical cannabis pathway, the product must be prescribed by a specialist doctor listed on the General Medical Council (GMC) specialist register. The prescription only happens after a rigorous assessment. There is no “walk-in” service. There is no “one-size-fits-all” protocol. If a clinic tells you otherwise, run.
What Does the Appointment Actually Look Like?
I ask this question in every interview I conduct with founders and clinicians: “What does the appointment actually look like?” If they can’t answer with granularity, they aren’t doing it right. In a regulated digital health clinic, the journey is rarely what the uninitiated expect.
It starts with online eligibility checks. This isn’t a digital “fun quiz.” It is a screening tool designed to filter out those who are clearly ineligible based on their history—for instance, patients with certain psychotic disorders or cardiovascular issues. If the patient passes this preliminary check, they are moved to a clinical consultation. This is conducted via telemedicine, connecting the patient with a consultant who has experience in the specific condition being treated, whether that’s chronic pain, treatment-resistant epilepsy, or refractory anxiety.
The Workflow of a Regulated Consultation
The Shift: From Wellness Trends to Functional Health
We are currently in a transition period in the health industry. For years, “wellness” has been defined by aesthetic trends: jade rollers, expensive powders, and vague promises of “life-changing” transformations. I hate that phrase. When a founder tells me their product is “life-changing,” I ask for the data. Usually, they don’t have it. When we move the conversation to medical cannabis, we have to strip away that hyperbole.
Functional health is not about how you look on Instagram. It’s about being able to walk your dog without a flare-up of chronic pain. It’s about being able to sit in a meeting without your anxiety spiking to a point of physical distress. It is about day-to-day functioning. Regulated healthcare providers understand that a patient’s success is measured by the return of their autonomy, not by a transcendent spiritual experience.
This is why clinical oversight is the only way this industry remains viable. If a patient experiences a side effect—a racing heart, dizziness, or a lack of expected efficacy—the consultant needs to be available to adjust the regimen. This is the difference between medicine and guesswork.
Safety: The Non-Negotiable Metric
Why do we talk so much about safety? Because cannabis is a pharmacological agent. It has active ingredients that interact with other drugs. It can affect blood pressure. It can interact with how your liver metabolizes other medications. Ignoring these facts in favor of a “natural is always better” narrative is dangerous and anti-intellectual.
The safety framework isn’t just about the product; it’s about the patient’s context. A regulated clinic will ask about your work life, your driving, your family history. They aren’t just prescribing a substance; they are integrating that substance into a complex human life. That is the essence of regulated healthcare.
Moving Away from the One-Size-Fits-All Trap
One of the most persistent myths is that “cannabis is cannabis.” This is why mixing up CBD products with prescribed cannabis-based medicines is a massive public health oversight. CBD is a non-intoxicating compound, but medical cannabis—when prescribed for complex conditions—often utilizes THC in precise, controlled quantities to achieve a therapeutic effect.
Trying to manage a chronic, complex, or treatment-resistant condition with off-the-shelf products is like trying to fix a faulty electrical system with duct tape. This reminds me of something that happened made a mistake that cost them thousands.. It might stick for a second, but it isn’t an engineered solution. Individualized care means that two patients with the same diagnosis might receive entirely different formulations and dosages. The regulation ensures that this personalization happens within the anxiety symptoms support safety bounds of clinical science, not through a process of trial-and-error in a vacuum.
Conclusion: The Future of the Conversation
If we want to stop treating medical cannabis like a hush-hush fringe movement and start treating it like a legitimate branch of healthcare, we have to stop romanticizing it. We have to demand the same standards of patient safety and clinical oversight that we demand for any other branch of medicine. We have to be the ones asking the tough questions: “What is your titration protocol?” “How do you manage potential drug interactions?” “What is the clinical evidence for this specific formulation?”
The shift from “wellness” to “function” is the most encouraging development I’ve seen in my career. Patients deserve to be treated as partners in their own health journey, not as consumers of a trend. Medical cannabis is simply a tool—a sophisticated, regulated tool—that, when used correctly by clinicians, can help shift the baseline of a patient’s quality of life. Let’s focus on that. Let’s focus on the patient, the clinical evidence, and the safety that keeps both of them grounded.
Because ultimately, the most “life-changing” thing that can happen in healthcare is simply getting the right, safe, and effective treatment for the person in front of you. No hype required.
